Issue 66, 2016, Issue in Progress
From the journal:

RSC Advances

Correction: IDO as a drug target for cancer immunotherapy: recent developments in IDO inhibitors discovery

Shan Qian,*a   Man Zhang,a   Quanlong Chen,a   Yanying He,a   Wei Wanga  and  Zhouyu Wang*b  

* Corresponding authors

a Department of Pharmaceutical Engineering, Xihua University, Chengdu 610039, P. R. China
E-mail: qians33@163.com

b Department of Chemistry, Xihua University, Chengdu 610039, P. R. China
E-mail: zhouyuwang77@gmail.com

Abstract

Correction for ‘IDO as a drug target for cancer immunotherapy: recent developments in IDO inhibitors discovery’ by Shan Qian et al., RSC Adv., 2016, 6, 7575–7581.

About
Cited by
Related
Download options Please wait...

Associated articles

Article information

DOI
https://doi.org/10.1039/C6RA90050J
Article type
Correction
Submitted
25 May 2016
Accepted
25 May 2016
First published
27 Jun 2016
This article is Open Access
Creative Commons BY license

RSC Adv., 2016,6, 61267-61267

Permissions

Request permissions

Correction: IDO as a drug target for cancer immunotherapy: recent developments in IDO inhibitors discovery

S. Qian, M. Zhang, Q. Chen, Y. He, W. Wang and Z. Wang, RSC Adv., 2016, 6, 61267 DOI: 10.1039/C6RA90050J

This article is licensed under a Creative Commons Attribution 3.0 Unported Licence. You can use material from this article in other publications without requesting further permissions from the RSC, provided that the correct acknowledgement is given.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements